IRIS
CUTAIA, ORNELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.696
EU - Europa 1.247
AS - Asia 628
SA - Sud America 106
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 32
OC - Oceania 1
Totale 3.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.665
RU - Federazione Russa 343
SG - Singapore 251
IT - Italia 246
IE - Irlanda 204
GB - Regno Unito 157
CN - Cina 155
BR - Brasile 87
VN - Vietnam 87
SE - Svezia 61
FR - Francia 52
DE - Germania 51
HK - Hong Kong 50
UA - Ucraina 41
FI - Finlandia 25
ES - Italia 23
ZA - Sudafrica 20
IN - India 19
BD - Bangladesh 14
CA - Canada 14
MX - Messico 13
EC - Ecuador 8
IQ - Iraq 8
KR - Corea 8
PL - Polonia 8
AT - Austria 7
CO - Colombia 6
JP - Giappone 6
TR - Turchia 6
LT - Lituania 5
NL - Olanda 5
CH - Svizzera 4
BE - Belgio 3
DZ - Algeria 3
PH - Filippine 3
CI - Costa d'Avorio 2
CR - Costa Rica 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AR - Argentina 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.710
Salva come PNG Salva come JPEG
Città #
Dublin 203
Fairfield 198
Ashburn 154
Singapore 141
Southend 123
Dallas 108
Moscow 97
Woodbridge 92
San Jose 89
Santa Clara 89
Cambridge 84
Seattle 75
Houston 65
Wilmington 65
Beijing 59
Hong Kong 49
Milan 46
New York 43
Siena 40
Jacksonville 36
Chandler 33
Ann Arbor 30
Princeton 28
Ho Chi Minh City 27
Los Angeles 25
The Dalles 24
Council Bluffs 23
Shanghai 21
Johannesburg 19
Lauterbourg 18
San Diego 18
Rome 17
Helsinki 15
Munich 15
Málaga 15
San Mateo 14
Hanoi 12
Denver 11
Dong Ket 11
Hefei 11
Palermo 9
Stockholm 9
Brooklyn 8
Buffalo 8
Florence 8
Seoul 8
São Paulo 7
Boston 6
Columbus 6
Dearborn 6
Orem 6
Piscataway 6
San Francisco 6
Tokyo 6
Turku 6
Warsaw 6
Boardman 5
Labico 5
Montreal 5
Nanjing 5
Nuremberg 5
Phoenix 5
Poplar 5
San Giovanni Valdarno 5
Atlanta 4
Avon 4
Barnet 4
Charlotte 4
Chicago 4
Düsseldorf 4
Fremont 4
Guayaquil 4
Hounslow 4
Redondo Beach 4
Redwood City 4
Venezia 4
Zurich 4
Araxá 3
Asciano 3
Borgo San Lorenzo 3
Brussels 3
Chennai 3
Da Nang 3
Empoli 3
Figino 3
Frankfurt am Main 3
Genoa 3
Hải Dương 3
Istanbul 3
Lavis 3
London 3
Medellín 3
New Delhi 3
Ninh Bình 3
Querétaro 3
Secaucus 3
Toronto 3
Trieste 3
Turin 3
Vienna 3
Totale 2.515
Salva come PNG Salva come JPEG
Nome #
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 336
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: Results of a phase II study 329
Immunomodulatory properties of DNA hypomethylating agents: Selecting the optimal epigenetic partner for cancer immunotherapy 272
Circulating levels of PD-L1 in mesothelioma patients from the NIBIT-MESO-1 study: Correlation with survival 259
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 249
Guadecitabine plus ipilimumab in unresectable melanoma: the NIBIT-M4 clinical trial 235
NK- and T-cell subsets in malignant mesothelioma patients: Baseline pattern and changes in the context of anti-CTLA-4 therapy 235
“Cancer Bio-Immunotherapy in Siena”: Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8–10, 2015 215
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 208
“Cancer Bio-Immunotherapy in Siena”: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17–19, 2013 204
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications 189
CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy? 176
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012 161
ICOS expression as immunologic marker in immune activating monoclonal antibodies 152
“Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014 148
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 146
Safety and immunobiological activity of guadecitabine sequenced with ipilimumab in metastatic melanoma patients: The phase Ib NIBIT-M4 study 139
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 123
Totale 3.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022219 0 43 20 6 9 11 13 9 6 25 36 41
2022/2023231 19 13 36 18 8 42 10 16 24 16 19 10
2023/2024329 16 8 35 15 11 94 111 5 5 5 14 10
2024/2025497 15 19 57 18 72 36 15 27 62 22 43 111
2025/20261.391 88 147 79 202 390 65 154 49 15 57 43 102
2026/202796 53 43 0 0 0 0 0 0 0 0 0 0
Totale 3.776